Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial

Faster, Cleaner, Better.

Genmark Diagnostics (GNMK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2010	09-2010	06-2010	03-2010	12-2009
Cash Flows From Operating Activities
Net Income	-18,400	N/A	-9,980	N/A	N/A
Depreciation Amortization	1,060	N/A	460	N/A	N/A
Accounts receivable	-508	N/A	N/A	N/A	N/A
Accounts payable and accrued liabilities	-1,058	N/A	N/A	N/A	N/A
Other Working Capital	-3,070	N/A	-400	N/A	N/A
Other Operating Activity	3,116	0	820	0	0
Operating Cash Flow	$-18,860	$N/A	$-9,100	$N/A	$N/A

Cash Flows From Investing Activities
PPE Investments	-1,860	N/A	-570	N/A	N/A
Investing Cash Flow	$-1,860	$N/A	$-570	$N/A	$N/A

Cash Flows From Financing Activities
Debt Repayment	5	N/A	N/A	N/A	N/A
Common Stock Issued	27,600	N/A	N/A	N/A	N/A
Other Financing Activity	-4,995	0	22,850	0	0
Financing Cash Flow	$22,610	$N/A	$22,850	$N/A	$N/A

Exchange Rate Effect	-40	N/A	-40	N/A	N/A
Beginning Cash Position	16,480	N/A	16,480	N/A	N/A
End Cash Position	18,320	N/A	29,600	N/A	N/A
Net Cash Flow	$1,840	$N/A	$13,120	$N/A	$N/A

Free Cash Flow
Operating Cash Flow	-18,860	N/A	-9,100	N/A	N/A
Capital Expenditure	-1,860	N/A	N/A	N/A	N/A
Free Cash Flow	-20,720	0	-9,100	0	0